Journey to complete remission of dysplasia and intestinal metaplasia after ESD and EMR of Barrett’s esophagus-related neoplasia
Despite larger lesion sizes and more cancers in patients undergoing ESD, the EET journey to achieving CRD and CRIM was comparable to that in patients receiving cEMR. Prospective studies are required to further study differences between these two treatment approaches.
Authors
- Nikita Garg
- Kenneth T. Wang (ORCID: https://orcid.org/0000-0002-7720-2431)
- Prasad G. Iyer (ORCID: https://orcid.org/0000-0002-9822-1420)
- Amit Bhatt
- John J. Vargo (ORCID: https://orcid.org/0000-0001-7638-5283)
- Sunguk Jang
- William S. Harmsen (ORCID: https://orcid.org/0000-0001-7134-5362)
- Rohit Goyal (ORCID: https://orcid.org/0000-0001-6307-0055)
- Don C. Codipilly (ORCID: https://orcid.org/0000-0003-3197-0539)
- Abel Joseph (ORCID: https://orcid.org/0000-0002-5446-6127)
- Kornpong Vantanasiri (ORCID: https://orcid.org/0000-0001-7882-4294)
- Cadman L. Leggett (ORCID: https://orcid.org/0000-0002-0495-3795)
Institutions
- Cleveland Clinic (US)
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
- Stanford University (US)
Publication Details
- Journal
- Endoscopy International Open
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1055/a-2422-2815
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00